Related Experiment Videos
Percutaneous transcatheter therapy of aorto-ostial stenoses
1Christ Hospital Cardiovascular Research Center, Cincinnati, Ohio 45219, USA.
Insights
Percutaneous transcatheter therapy for aorto-ostial stenoses has improved outcomes. Ablative technologies and stenting offer better success rates and fewer complications for these challenging lesions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Native coronary and saphenous vein graft aorto-ostial stenoses historically had lower success rates with balloon angioplasty (PTCA).
- These lesions were associated with increased in-hospital complications and late restenosis compared to non-ostial stenoses.
Purpose of the Study:
- To evaluate the impact of modern interventional techniques on aorto-ostial stenoses.
- To highlight advancements in percutaneous treatment strategies for complex aorto-ostial disease.
Main Methods:
- Review of outcomes associated with balloon angioplasty (PTCA) for aorto-ostial stenoses.
- Assessment of the role of ablative technologies and intracoronary stents in percutaneous intervention.
- Evaluation of improvements in stent technology for aorto-ostial lesions.
Main Results:
- Ablative technologies and intracoronary stents have significantly improved early and late outcomes for aorto-ostial disease.
- Optimal treatment often involves decalcification or tissue ablation followed by stent deployment.
- Advancements in stent design enhance deployment and may further improve outcomes.
Conclusions:
- Percutaneous transcatheter therapy, particularly with stenting and ablative techniques, offers improved outcomes for aorto-ostial stenoses.
- Modern stent technology plays a crucial role in facilitating successful treatment and improving patient results.
- These advancements represent a significant step forward in managing complex aorto-ostial lesions.
Abstract:
The treatment of native coronary and saphenous vein graft aorto-ostial stenoses with balloon angioplasty (PTCA) has been associated with lower procedural success rates, more frequent in-hospital complications and a greater likelihood of late restenosis when compared with PTCA of non-ostial stenoses. The advent of ablative technologies and intracoronary stents have significantly altered both early and late outcomes of percutaneous intervention for aorto-ostial disease. The optimal approach to this complex lesion subset often involves decalcification or tissue ablation followed by stent deployment. Improvements in currently available stent technology including enhanced radial force and visibility, reduced thrombogenicity, and the availability of shorter stent lengths, may also facilitate stent deployment and further improve outcomes following percutaneous transcatheter therapy for aorto-ostial stenoses.